All posts by imreal

Health

Shuckin’ Shack Raises $80K for the Leukemia and Lymphoma Society with Second Annual Fresh & Raw Tour

Leave a comment


The oyster bar nearly doubled its impact compared to its inaugural live music tour in 2022, traveling to 16 cities in just four weeks.

WILMINGTON, N.C., Nov. 8, 2023 /PRNewswire-PRWeb/ — After a month-long community party that spanned 16 cities and 3,500 miles, Shuckin’ Shack, the oyster bar franchise, is celebrating $80,000 raised for the Leukemia and Lymphoma Society (LLS). Its 2023 Fresh & Raw Tour, presented in partnership with Truist, was a major hit, spotlighting Barrett Baber, a country rockstar who took off after appearing on NBC’s The Voice, and Taylor Goyette, an up-and-coming Nashville artist with a raw, soulful sound. This dynamic duo, paired with Shuckin’ Shack’s fresh oysters and cold beer, made for the perfect community get-together benefitting a great cause.

“In the hospitality business, people seek places where they feel welcomed and served. They seek an experience that makes them feel like they belong there. We believe that a big part of that belonging is our desire to get involved with the communities where we have restaurants,” said Jonathan Weathington, CEO of Shuckin’ Shack. “For us, that community extends beyond city limits and restaurant walls. When we’re talking about a community of people affected by cancer, we’re extending our reach beyond any geographics. We don’t use Fresh & Raw as a publicity stunt, we truly don’t make any money off of it. Fresh & Raw is for our customers and their families – giving them a place to come and celebrate life and togetherness, all for the benefit of seeking cures for terrible diseases.”

Fundraising for the Leukemia and Lymphoma Society is incredibly important for the Shuckin’ Shack network as Co-Founder Matt Piccinin is a survivor of Leukemia, largely thanks to the funds raised by the Society that empower further research and treatments for Leukemia patients.

The Fresh & Raw Tour created an opportunity for the entire system to raise money for the Leukemia and Lymphoma Society in a fun way. Rather than focusing on how many people were in attendance or ways the system could increase its own revenue thanks to the tour, the team funneled its energy toward increasing its impact for the Leukemia and Lymphoma Society and local communities.

“I’m so glad I had the pleasure to be able to join my friend and co-writer Barrett Baber for the Fresh & Raw Tour at Shuckin’ Shack Oyster Bars,” said Goyette. “It was a heartwarming experience being able to lift the spirits of so many people affected by such a horrible disease and raise so much money for a wonderful cause. I really enjoyed getting to know some folks and getting to hear their personal stories. Being able to do all that while playing music was just the cherry on top.”

“As a songwriter, it’s always a pleasure to get the opportunity to play original songs in new cities for new people,” added Baber. “The fact that we raised so much money for such a great cause makes it even more special. It was a tour I’ll never forget.”

The last stop of the tour, in Carolina Beach, North Carolina, punctuated the entire experience perfectly and really highlighted the power of the Shuckin’ Shack system, its leadership team, its guests and its partners.

Though the Carolina Beach Shack technically has just 35 seats, there were 500 people in attendance for the Fresh & Raw Tour, meaning the crowd — and great vibes — spilled out into the parking lot and street.

“This tour meant way more to attendees than just a live music series, and the overflowing Carolina Beach event is a perfect illustration of this,” said Darren Keeler, Vice President of Marketing. “There was live music, cold beer and fresh oysters, but the guests were here to raise money for LLS and come together as a community. We heard moving personal stories at every stop of the tour as we spoke to attendees who felt deeply connected to the cause, and the privilege to support these people and their communities is one of the biggest honors of the tour.”

One of the most memorable guests was Lynn Bridges, a two-time non-hodgkin survivor who was also diagnosed with Leukemia in 2021 but has been in remission for over a year now. Bridges loved visiting her local Shuckin’ Shack for meals, but when she learned of the Fresh & Raw Tour, she was excited to attend. Having survived both lymphoma and leukemia, any opportunity to support the Leukemia and Lymphoma Society is something she’s interested in. After attending the first event at Surf City, NC and having a great time, she decided to go to the Wilmington and Carolina Beach, NC events, too.

“From the very first day, Taylor and Barrett were so welcoming and warm to everyone. I went and thanked them for their contributions after the first event, then I met Darren. We all took pictures and talked and cried together,” said Bridges. “Everyone just made me feel so warm and welcomed. The staff of Shuckin’ Shack is the most wonderful staff I’ve ever met. They really make you feel like they care about you and want you to enjoy your time. It was that great experience that led me to Wilmington.”

Again, at the Wilmington and Carolina Beach locations, Bridges had a great time, shared her story and connected with other survivors and community members in support of a cause incredibly close to her own heart.

“I can’t tell you how uplifting all of this was for me. These people were complete strangers, but they made me feel so comfortable,” she explained. “I may never see some of these staff members again, but the way they reached out to me made me feel that they were with me 100%. It really warmed my and my husband’s hearts. I’ll never forget those three days.”

“People like Lynn are the reason why we are so committed to doing this tour every year and continuing to contribute to the culture and connection of the communities we enter,” added Keeler. “We’re already looking forward to the next round of concerts, delicious seafood, an even bigger fundraising goal and A Good Shuckin’ Time at Fresh & Raw 2024.”

ABOUT SHUCKIN’ SHACK:
Shuckin’ Shack Oyster Bar grew out of a vision for a local establishment that would appeal to families of all ages. A place where friends and family can enjoy fresh, delicious meals and creative cocktails in an environment that exudes relaxation. Shuckin’ Shack offers its guests a “lifestyle experience” in addition to exceptional seafood. The brand started as a 900-square-foot shack in Carolina Beach, North Carolina, in 2007 and began franchising in 2014. Today, Shuckin’ Shack has grown to 18 locations across six states. To learn more about Shuckin’ Shack, visit http://www.theshuckinshack.com.

Media Contact

Julie Maw, Mainland, 3125263996, [email protected], www.hellomainland.com

SOURCE Shuckin’ Shack

Lifestyle: Self Help

Dental Care Alliance Welcomes Atlanta Center for Cosmetic Dentistry of Atlanta, GA

Leave a comment


At the core of the practice lies a philosophy rooted in aesthetic dentistry, a patient-centric approach, and an unwavering commitment to delivering extraordinary results. The practice has become a trusted destination for individuals seeking comprehensive cosmetic dental solutions through their innovative approach to care, including the Custom Smile Design Experience, an innovative blend of patient goals and clinical expertise.

Dr. King is highly regarded and recognized in her community and across the nation. She has been featured on CBS, CNN, The Doctors, Fox News, and in The Wall Street Journal, Time Magazine, InStyle, Vogue, Glamour, and USA Today. She was also selected as a featured cosmetic dentist on ABC’s show, “Extreme Makeover”, has been awarded “Best Cosmetic Dentist” by Best Self Atlanta, and is a 2020 Dental Hall of Fame inductee. She also directs an active philanthropy program benefiting the greater Atlanta area and people around the world. Over the past few decades, ACCD has donated more than $1M to more than 60 charities.

Atlanta Center for Cosmetic Dentistry offers a full range of cosmetic, restorative, and general dentistry services including porcelain veneers, prepless ultra-thin veneers, cosmetic bonding, teeth whitening, gum shaping, full mouth construction, anti-aging dentistry, Invisalign, implants, bridges, and crowns; all with an eye for beautiful natural results.

Atlanta Center for Cosmetic Dentistry dentists are members of the American Academy of Cosmetic Dentistry and are passionate about creating beautiful smiles. They are the only practice in the world with four accredited dentists!

Dr. Debra Gray King graduated from the University of Tennessee Center for the Health Sciences in Memphis, TN in 1987. She passed the accreditation examinations of the American Academy of Cosmetic Dentistry (AACD) in 1995 and went on to earn her fellowship in that Academy in 1999. AACD Fellowship is recognized as the highest level of competence in cosmetic dentistry, and there are only 81 dentists in the world who have earned this distinction.

“This partnership with DCA marks a transformative milestone in my professional journey,” shared Dr. King. “Through meticulous research, DCA emerged as the beacon of integrity and philosophy that aligned seamlessly with ACCD’s long-standing ethos of excellence and heartfelt patient care. I am invigorated by the promise of this partnership—preserving ACCD’s cherished legacy and magnifying its reach. Our combined vision and expertise herald a new era in cosmetic dentistry, crafting a future punctuated with captivating smiles.”

Dr. Charles C. Cooper received a B.A. with honors in Science Education at Mississippi State University, a Doctor of Medical Dentistry degree at the University of Mississippi School of Dentistry, and performed a General Practice Residency Program at the Medical College of Georgia School of Dentistry. Dr. Cooper earned his accreditation with the AACD in 2014.

Dr. Brett C. Reeve graduated with honors from Brigham Young University where he combined studies of Science and Spanish. He then went on to study Dentistry at the University of Southern California where he earned membership to “Omicron Kappa Upsilon”. Following graduation, Dr. Reeve served as a Captain in the United States Air Force for four years. In 2022 Dr. Reeve earned his accreditation with the AACD.

Dr. Laura Justice graduated with honors from the University of Kentucky College of Dentistry and has been practicing dentistry since 1989. She is an Accredited Fellow of the American Academy of Cosmetic Dentistry and serves on the board of the AACD, as well as being an Accreditation Examiner.

This affiliation reinforces Atlanta Center for Cosmetic Dentistry’s commitment to delivering the highest standard of dental care and ensuring access to innovative treatments for patients across the region. Additionally, this affiliation continues the rapid growth and momentum for the organization and expands DCA’s footprint in Georgia to 23 allied practices, and DCA’s total footprint to over 400 allied practices across the US.

“It’s with tremendous pride that we welcome the highly regarded practice of Atlanta Center for Cosmetic Dentistry to the DCA family,” shared Mandy Gast, DCA VP of Business Development. “Dr. King and her team are a vision into the future of what excellence in dentistry looks like, and we couldn’t be prouder to be their partner of choice.”

Dental Care Alliance’s mission is to advance the practice of dentistry by partnering with and supporting dental professionals to create a lifetime of healthy smiles. DCA currently supports over 400 allied practices and over 900 dentists across 23 states. DCA’s allied practices represent all dental specialties and treat patients under more than 150 brand names.

Media Contact

Molly Benz, Dental Care Alliance, 9419553150, [email protected], dentalcarealliance.com 

SOURCE Dental Care Alliance

Health

Mytonomy Recognized by Deloitte as One of the 500 Fastest-Growing Tech Companies in North America

Leave a comment


“In today’s complex healthcare environment, it’s essential to provide health education and support in a manner that meets the needs of each patient, ensuring that they can readily learn how to care for themselves,” said Anjali Kataria, CEO and Co-founder of Mytonomy. “We are honored to be named to the Deloitte Technology Fast 500 and are dedicated to driving our technology forward by partnering with leading hospitals, payors, and pharma companies to save clinicians’ time, enhance both patient and staff experience and help drive better outcomes.”

Mytonomy Cloud for Healthcare is the enterprise platform enabling healthcare providers to engage effectively with their patients digitally. The platform enhances the patient experience and automates practitioner workflow by employing video content streaming, combined with automated intelligent patient/provider communication and outreach around the most frequently asked questions. Currently used by more than 70 hospitals, 200 clinics, and 11 academic medical centers across the U.S., and several payors and pharma/med device companies, Mytonomy has harnessed the best practices of digital engagement to become a leader in digital patient education and automation, delivering improved outcomes and results for customers. Mytonomy supports every major medical condition across all care settings, facilitating more than 300 patient journeys out of the box.

“Each year we look forward to reviewing the progress and innovations of our Technology Fast 500 winners. This year is especially celebratory as we expand the number of winners to better represent just how many companies are developing new ideas to progress our society and the world, especially during a slow economy,” said Paul Silverglate, vice chair, Deloitte LLP and U.S. technology sector leader. “Congratulations to all the winners who show us how creativity, hard work and perseverance can lead to success.”

Overall, the 2023 Technology Fast 500 companies achieved revenue growth ranging from 201% to 222, 189% over the three-year time frame from 2019 to 2022, with an average growth rate of 1,934% and a median growth rate of 497%.

“As for growing companies, it’s always rewarding to be recognized for the ongoing commitment it takes to navigate obstacles, transform when necessary and ultimately create a thriving business,” said Christie Simons, partner, Deloitte & Touche LLP and industry leader for technology, media and telecommunications within Deloitte’s audit and assurance practice.

About Mytonomy
Mytonomy Inc, based in Bethesda, MD is a leading provider of healthcare cloud solutions for video-based patient education and engagement. The company leverages the power of content streaming and intelligent patient/provider communication to automate the clinical workflow and deliver a great patient/provider experience. Mytonomy Cloud for Healthcare is used at 70+ hospitals, and 200+ clinics to help reduce inbox, save clinician time, improve outcomes, and reduce costs. The enterprise platform provides a seamless, consumer-like experience across all major medical conditions, pre/post procedure, ambulatory, inpatient and at home care, and fully integrates with all major EHR and CRM systems. Mytonomy has been named to the Inc. 5000 List of Fastest Growing Companies in the U.S. four years in a row and was recognized as Best SaaS Platform for Healthcare in 2022 by The Cloud/SaaS Awards. Mytonomy’s clinical studio has received over 150 Telly, Digital Health and Health Information Awards for excellence in clinical education. To learn more about Mytonomy Cloud for Healthcare and our Patient Experience Cloud™ visit our website: http://www.mytonomy.com and follow us on LinkedIn.

Media Contact

Ellie Hanson, Mytonomy, 929-588-2006, [email protected], www.mytonomy.com

SOURCE Mytonomy

Health

Beth Israel Lahey Health Performance Network deploys Radial’s decision support platform to optimize transitions of care

Leave a comment


Smart Placement AI/ML solutions deliver actionable insights to optimize care team decisions.

CONCORD, Mass., Nov. 8, 2023 /PRNewswire-PRWeb/ — Radial, a leading provider of decision support software for transitions of care, is excited to announce a new customer agreement with Beth Israel Lahey Health Performance Network (BILH Performance Network). Radial’s cloud-based Smart Placement platform is now live at Beth Israel Deaconess Medical Center, Lahey Hospital & Medical Center, and Mount Auburn Hospital. The implementation will expand as the partnership develops, extending to other hospitals within the BILH system.

Under this new partnership, Radial’s technology is deployed for approximately 90,000 Medicare beneficiaries aligned to Accountable Care Organizations (ACOs) managed by BILH Performance Network. Radial’s decision support platform provides predictive insights to care management teams in real time, beginning on the very first day of a patient’s hospital stay. Users and supervisors also benefit from Radial’s live monitoring features, which help to assess patient outcomes, staff efficacy, and resource utilization.

“We are excited to embark on this collaborative journey with BILH Performance Network in support of their mission to create healthier communities – one person at a time – through seamless care,” said Thaddeus Fulford-Jones, CEO of Radial. “With the addition of BILH Performance Network, Radial’s health system customers account for almost 50% of all acute hospital stays across Massachusetts. We’re delighted that our solutions are positively impacting so many patients and care teams.”

For more information, please visit radialanalytics.com

For press inquiries, please contact [email protected]

About Radial

Funded in part by Initialized Capital, NIH, and the National Science Foundation, Radial builds AI/ML solutions to optimize patient care transitions. Radial’s real-time decision support platform empowers clinical staff to intervene when it matters most.

SOURCE Radial

Health: Addiction

Trialbee’s Jamie Goldfarb Earns Linnea Olson Award for Lifelong Advocacy Connecting Patients With Clinical Research

Leave a comment


Goldfarb was diagnosed with melanoma for a third time in January 2011 — 11 weeks after giving birth to her son, Kai. The cancer had reached stage 4 by metastasizing to her liver and pancreas, and Goldfarb enrolled in a clinical trial for tumor-infiltrating lymphocyte (TIL) therapy as part of her treatment.

Because of the clinical trial, she reached no evidence of disease two years post treatment (during which time the 40-plus tumors all over her body shrank until they disappeared) and has remained disease free for the past 11 years.

Throughout her experience, Goldfarb realized not all patients are aware of clinical research opportunities that may be available to them, especially in oncology. As a result, she embraced the opportunity to be a vocal patient advocate even outside of her professional responsibilities in clinical trial patient recruitment by speaking at industry and patient conferences, writing articles and white papers, speaking with the media about the importance of clinical trials, and working one-on-one with people with cancer to help them navigate their treatment options.

“This is a humbling recognition for something I’m very passionate about,” Goldfarb said. “I don’t share my story because I want to be in the spotlight. I do it because a clinical trial saved my life, yet less than 5% of patients with cancer ever participate in clinical research. I want everyone to understand the power and potential of clinical trials as a treatment option — and more importantly, I want to provide hope and clarity to anyone who feels like they’re up against the odds during a discouraging and confusing time.”

Goldfarb gave the keynote address at the Melanoma Research Alliance’s (MRA) annual scientific retreat in Washington, D.C., in March and has spoken about how medical professionals must improve awareness of clinical trials among patients at various industry events.

Goldfarb has been a research advocate for the National Cancer Institute (NCI), which uses her perspective to ensure the patient’s experience is considered throughout the research process. She is one of the patient moderators of the MRA’s patient forum, and created patient-centric online clinical trial resources for the organization as well as several top-20 global pharmaceutical companies. She is also heavily involved with the Melanoma International Foundation (MIF), the Melanoma Research Foundation (MRF), the Alliance for Regenerative Medicine (ARM), the Association of Clinical Research Professionals (ACRP), and Imerman Angels. She and her husband, Jeff, have met with members of Congress to push for increased funding for the NCI and National Institutes of Health (NIH).

As valuable as her public advocacy work is, Goldfarb believes one-on-one outreach with patients makes the greatest difference. She helps them navigate their treatment options, including how medical research works, what a clinical trial is, and whether it’s right for them. She then connects them with others battling cancer so they can build a stronger support system.

“In a sea of worthy and passionate candidates, there’s no one more deserving than Jamie,” said Matt Walz, CEO of Trialbee. “It’s not just about how she has carried herself in the face of tremendous adversity. It’s about how she has channeled her struggles into empowering and uplifting others facing similar battles. Jamie embodies hope and resiliency in the most inspiring way. She’s been an incredible asset to the Trialbee family, and we are lucky to have her.”

Goldfarb accepted the Linnea Olson Award at the Medidata NEXT New York conference at the Sheraton New York Times Square Hotel on November 7.

“I just want patients to always remember they are not alone,” Goldfarb said. “Talk to friends. Family. Healthcare providers. Don’t stop talking until you understand all your options.”

About Trialbee

Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company’s vendor-agnostic Honey Platform™ is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment – providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step pre-qualification, and meaningful Omnichannel partners focused on patient advocacy, community engagement, and diversity. To take control of patient recruitment for your next study, visit http://www.trialbee.com/.

Media Contact

Kristopher Sarajian, Trialbee, 1 6102282096, [email protected], www.trialbee.com

SOURCE Trialbee

Health

AvevoRx Welcomes Denise Stechman as its New Regional Director of Managed Care

Leave a comment


She holds a Master of Arts in Judicial Management and a Bachelor of Arts in Criminal Justice (Pre-Law) from the University of Nevada at Reno, where she now lives.

“I have an innate passion for helping people and took an interest in healthcare and law very early on,” says Ms. Stechman. “Pharmacy offered me the chance to do everything I love – building relationships, working with payors large and small, and serving the most vulnerable patient populations to get the care they need. I am grateful to join a team that shares these values and is as obsessed as I am with simplifying the patient experience.”

“Our growth over the past year has been rapid, and we continuously see opportunities to partner with additional managed care plans in Western markets,” said Eric Hill, co-founder of AvevoRx. “Denise’s experience and focused leadership over this area ensures that we can build out a team to support new contracts for years to come and help reach as many patients as possible. A robust portfolio of managed care partners helps boost the level of service and simplicity we can offer them and payors alike.”

AvevoRx currently holds licenses in 26 states across the country. Visit AvevoRx.com for more information.

About AvevoRx

AvevoRx is a bespoke, independent provider of specialty infusion pharmacy services. The company focuses on the highest-quality, personalized care customized to patients facing various complex, chronic disorders. Treatments are made available via specialized pharmacy locations, field nurses, and additional support staff throughout the United States. AvevoRx also provides acute infusion therapies for patients with short-term therapeutic needs on a regional basis. Privately held, the company was founded in 2021 by a small group of industry veterans with a combined experience of more than 130 years. AvevoRx is headquartered in North Carolina. To learn more, visit www.AvevoRx.com or follow us on Instagram or LinkedIn.

Media Contact

Victoria Seremeta, AvevoRx, 1 5162861950, [email protected], www.AvevoRx.com 

SOURCE AvevoRx



Health

HHAeXchange Honors Ten Homecare Heroes in Observance of National Homecare & Hospice Month

Leave a comment


Caregivers from the following agencies were selected as Homecare Heroes:

“In honor of this month’s observance, we wanted to celebrate the soul of our industry, the caregivers,” said Paul Joiner, Chief Executive Officer, HHAeXchange. “Caregiving is not just a job – it’s a calling. They show up every day with kindness, compassion, and dedication, and we could not be more proud to support them with our work at HHAeXchange.”

The 10 caregivers who were selected, and their agencies, will be celebrated via social media. Each of the caregivers will also receive a $500 Visa gift card, and their agency will be given a $250 gift card. The HHAeXchange Homecare Heroes nominations will be held on an annual basis each November in honor of National Home Care & Hospice Month.

To learn more about HHAeXchange and the honored Homecare Heroes, please visit hhaexchange.com and follow the company on Twitter, LinkedIn and Facebook.

Media Contact

Michelle Rand, Alloy, on behalf of HHAeXchange, 855.300.8209, [email protected], hhaexchange.com

SOURCE HHAeXchange



Science: Biology

DTS Achieves Perfect Score on Joint Surveillance Voluntary Assessment

Leave a comment


“We have spent countless hours understanding and implementing the requirements of DFARS 252.204-7012 and CMMC Level 2 requirements to achieve this goal,” explained Edward Tuorinsky, DTS Managing Principal. “This achievement demonstrates to our DoD customers that we take protecting their information seriously, and that we have proven experience needed to deliver white-glove CMMC Level 2 remediation to help other DIB contractors achieve the same level of security.”

DTS customer IVA’AL Solutions, an 8(a) contractor, made the choice to apply for the Joint Surveillance Voluntary Assessment Program (JSVAP) for competitive differentiation. DTS guided IVA’AL Solutions through the assessment process in August.

JSVAP is a collaboration between Cyber AB and the Defense Industrial Base Cybersecurity Assessment Center (DIBCAC). These are voluntary assessments for companies that believe they are already meeting or exceeding compliance requirements.

DTS Cyber Services spans the cybersecurity lifecycle, helping businesses establish and maintain a culture of security with solutions, systems, and policies. Services include cybersecurity posture assessments; remediation services; managed cybersecurity and IT for ongoing monitoring and maintenance, training, and emergency response; and Fractional CIO support, supplying customers with a senior technology leader who understands the business objectives and can provide technical direction. As an AvePoint partner, DTS expands and improves its offerings to end-customers.

DTS also offers DTS CyberSchool, an online educational offering that includes courses, learning modules, and a cybersecurity awareness training solution that allows small businesses to meet basic cybersecurity requirements in-house. The newest offering, Cyber Track: Basic, guided online course explains key concepts for the 15 FAR security requirements and 17 minimum security controls required for CMMC Level 1 and provides step-by-step instructions for how to document each one for compliance.

For more information, please visit DTS Cyber Services. For more information on DTS CyberSchool and how small businesses can be active participants in their own cybersecurity compliance, email [email protected].

About DTS

DTS is a Service-Disabled Veteran Owned Small Business, founded in 2011, delivering cyber, consulting, and management services—for exceptional results. Headquartered in Arlington, Virginia, DTS employs talented individuals with a passion for excellence and surrounds them with the resources they need to excel. For more than a decade, we have helped public sector and commercial clients respond to changing environments and daunting challenges by clarifying pathways, applying expertise, and managing implementation. To learn more about DTS, contact us at [email protected] or (571) 403-1841. Follow us on LinkedIn and Twitter. www.consultdts.com

Media Contact

Liz Smeds, JODER Communications (On Behalf of DTS), 1 7034449494, [email protected], https://consultdts.com/ 

SOURCE DTS



Health

Clinical Trials, Transformations and Regulations, Upcoming Webinar Hosted by Xtalks

Leave a comment


  •     Examine the diverse mechanisms of action underlying these psychedelic compounds, with a focus on serotonin 5HT2a receptor signaling.
  •     Discuss the important results observed in clinical trials, showcasing the potential for durable effects lasting over a year post-dosing.
  •     Highlight the pivotal role of organizations like MAPS (Multidisciplinary Association for Psychedelic Studies) in shaping the regulatory landscape for psychedelic medicines.
  •     Explore the pipeline of next-generation psychedelic medicines engineered for improved pharmacodynamic and pharmacokinetic effects, reduced toxicity, and a potential for retained efficacy without the hallucinatory aspects of current psychedelic compounds.

Gain insights into the recent guidance issued by the US FDA and explore the regulatory pathways for the clinical study and approval of psychedelics in both Australia and the United States.

Our panel of scientists and clinicians from Australia and the US will provide invaluable insights into ongoing trials, innovations in psychedelic therapies, and the regulatory pathways shaping the future of mental health treatment.

Don’t miss this opportunity to stay informed about the latest developments in psychedelic research and regulatory advancements.

Secure your spot now for this enlightening webinar with Avance Clinical.

Join experts from Avance Clinical, Jorgen Mould, Senior Director of Scientific & Regulatory Services; and Kevin Leach, Senior Vice President, Scientific & Regulatory Affairs, for the live webinar on Monday, November 27, 2023, at 10am PST (1pm EST).

For more information, or to register for this event, visit Psychedelics in Focus: Clinical Trials, Transformations and Regulations.

ABOUT AVANCE CLINICAL

Avance Clinical is a full-service CRO for biotechs with a proven track-record for delivering clinical excellence in Australia, New Zealand, and North America. As the largest premium full-service CRO in Australia and North America, Avance Clinical specializes in delivering top-tier clinical trials that yield globally accepted data.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks

Health: Mental Health

Clinical Trial Computerised Systems and Electronic Data

Leave a comment


The new guideline impacts sponsors, investigators and service providers involved in running clinical trials. Join this ICON webinar to gain the knowledge required to achieve compliance with the new regulatory regime, with a strong focus on data accuracy, security and operational efficiency of the trial.

Join Vesta Marciulioniene, Director, Global Regulatory Clinical Services, ICON Biotech; Cooper Brown, Senior Project Manager, DCT Solution Enablement, ICON; Berit Gorsøe Kjeldsen, Director, Project Management, ICON Biotech; and George Evgrafov, Senior Manager, Technology Quality Assurance, ICON, for the live webinar on Tuesday, November 28, 2023, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit Clinical Trial Computerised Systems and Electronic Data – Lessons Learned Implementing the New EMA Guideline.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks